PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$7.48
-0.27 (-3.48%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+578.3% upside
Low Target
$34.41
Average Target
$50.74
High Target
$70.04
Current Price
$7.48
Current
$7.48
$7.48
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Scenario Analysis
Bear Case
$34.41
360.0%
Low target
Base Case
$50.74
+578.3%
Avg target
Bull Case
$70.04
+836.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$18.31
-59.1% from high
52-Week Low
$7.59
+-1.4% from low
Target vs 52W High
$50.74
+177.1% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +13.7% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.3% |
| MRK | Buy | 36 | 72% | $159.27 | +5.5% |
| PFE | Hold | 36 | 39% | $33.90 | +21.4% |
| BMY | Hold | 35 | 43% | $174.50 | +180.3% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +188.0% |